Does Rallies show 13F holders for EWTX?

Yes. Rallies tracks hedge fund and 13F ownership data for EWTX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is EWTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EWTX. It does not provide personalized investment advice.

EWTX (Edgewise Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Edgewise Therapeutics, Inc. Common Stock (EWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, EWTX trades at $32.78 with a market cap of $3.41B and a P/E ratio of -20.05. EWTX moved +4.36% today. Year to date, EWTX is +39.24%; over the trailing twelve months it is +120.71%. Its 52-week range spans $10.60 to $39.96. Analyst consensus is strong buy with an average price target of $41.70. Rallies surfaces EWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns EWTX stock?

Hedge funds tracked by Rallies that own EWTX include Orbimed Advisors and Viking Global. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Edgewise Therapeutics, Inc. Common Stock.

EWTX Key Metrics

Key financial metrics for EWTX
Metric	Value
Price	$32.78
Market Cap	$3.41B
P/E Ratio	-20.05
EPS	$-1.63
Dividend Yield	0.00%
52-Week High	$39.96
52-Week Low	$10.60
Volume	627.89K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-167.79M
Gross Margin	0.00%

Top Hedge Funds Holding EWTX

Orbimed Advisors holds 15.52M shares of EWTX, changed +0.00% as of Mar 31, 2026.
Viking Global holds 490.04K shares of EWTX, changed -60.00% as of Mar 31, 2025.

Latest EWTX News

Edgewise Grants 72,000 Options at $32.46 Strike to Four New Hires — Apr 1, 2026
Edgewise Achieves 98%-Powered Sevasemten Trial with 175 Patients, Revises HCM Screening — Feb 13, 2026
Edgewise Secures $200M, Eyes Q4 Becker Trial Readout and H1 2026 HCM Data — Jan 13, 2026
Foresite Dumps 585,000 Edgewise Therapeutics Shares Worth $7.67M, Stock Falls 5.2% — Dec 30, 2025

Recent EWTX Insider Trades

Donovan Joanne M. sold 50.00K (~$1.93M) on May 5, 2026.
Donovan Joanne M. sold 5.23K (~$163.66K) on May 4, 2026.
Donovan Joanne M. sold 28.66K (~$926.10K) on Apr 1, 2026.

EWTX Analyst Consensus

10 analysts cover EWTX: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.70.

Common questions about EWTX

Who owns EWTX stock?: Hedge funds tracked by Rallies that own EWTX include Orbimed Advisors and Viking Global. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Edgewise Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for EWTX?: Yes. Rallies tracks hedge fund and 13F ownership data for EWTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EWTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EWTX. It does not provide personalized investment advice.